Finch Therapeutics Group, Inc.

FNCH · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$75-$115-$58
Dep. & Amort.$2$6$2
Deferred Tax-$3$0-$2
Stock-Based Comp.$2$8$4
Change in WC-$5-$2-$15
Other Non-Cash$49$28$1
Operating Cash Flow-$32-$75-$67
Investing Activities
PP&E Inv.$0-$2-$16
Net Acquisitions$0$0$0
Inv. Purchases$0$0$0
Inv. Sales/Matur.$0$0$0
Other Inv. Act.$1$0$0
Investing Cash Flow$1-$2-$16
Financing Activities
Debt Repay.-$16$15-$0
Stock Issued$0$0$119
Stock Repurch.$0$0$0
Dividends Paid$0$0$0
Other Fin. Act.$0$0$1
Financing Cash Flow-$16$15$119
Forex Effect$0$0$0
Net Chg. in Cash-$46-$62$36
Supplemental Information
Beg. Cash$74$136$100
End Cash$27$74$136
Free Cash Flow-$32-$77-$83